NCT04852172 - L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions

Acute Vaso Occlusive Crisis (VOC)

Interventions

DRUG

L-citrulline

L-citrulline is a naturally occurring amino acid. It is produced by, and normally present in, the human body.

OTHER

D5 1/2NS

Saline

Trial Locations (2)

Children's National Hospital, Washington D.C.

The University of Mississippi Medical Center, Jackson